# ALASCCA (NCT02647099)

> Adjuvant Low Dose Aspirin in Colorectal Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02647099
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Anna Martling
- Conditions: Colorectal Cancer
- Interventions: Acetylsalicylic acid; Placebo
- Enrollment: 626
- Primary outcome: Time To Recurrence (TTR)

## Commentary we found

- X threads: 31
- YouTube: 14
- Podcasts: 6

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=alascca-nct02647099

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02647099", "email": "<work email>"}; the inbox owner confirms by the emailed link.